Showing results (131-140 of 163) with videos related to
Sort By:
Pageof 17
British Journal of Audiology|March 4, 1999
Anomalous screening outcomes from click-evoked otoacoustic emissions and auditory brainstem response testsS Wood, S Mason, A Farnsworth, et al.Translational Oncology|March 26, 2017
Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian CancerC E Henry, C Emmanuel, N Lambie, et al.British Journal of Cancer|November 26, 2009
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalC A Barton, B S Gloss, W Qu, et al.The Journal of Urology|January 1, 1980
Comparison of intracellular flushing and cold storage to machine perfusion for human kidney preservationJ M Barry, J B Metcalfe, M A Farnsworth, et al.The Journal of Urology|February 1, 1982
Effect of donor surgeon on first cadaver kidney transplant functionJ M Barry, S M Fischer, D H Craig, et al.Cancer|May 15, 1996
Expression of cell regulatory proteins in ovarian borderline tumorsC van Haaften-Day, P Russell, C M Boyer, et al.Cancer Treatment Reviews|December 1, 1985
Intraperitoneal recombinant alpha 2-interferon for 'salvage' immunotherapy in persistent epithelial ovarian cancerJ S Berek, N F Hacker, A Lichtenstein, et al.Cancer Research|March 1, 1983
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvumR C Bast, J S Berek, R Obrist, et al.Cancer Research|September 1, 1985
Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group StudyJ S Berek, N F Hacker, A Lichtenstein, et al.American Journal of Obstetrics and Gynecology|August 15, 1985
Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvumJ S Berek, R C Knapp, N F Hacker, et al.Pageof 17